Transgenic Expression of Glud1 (Glutamate Dehydrogenase 1) in Neurons: In Vivo Model of Enhanced Glutamate Release, Altered Synaptic Plasticity, and Selective Neuronal Vulnerability by Bao, Xiaodong et al.
Cellular/Molecular
Transgenic Expression of Glud1 (Glutamate Dehydrogenase 1)
in Neurons: In Vivo Model of Enhanced Glutamate
Release, Altered Synaptic Plasticity, and Selective Neuronal
Vulnerability
Xiaodong Bao,1,2 Ranu Pal,1,2,3 Kevin N. Hascup,4 Yongfu Wang,5 Wen-Tung Wang,6 Wenhao Xu,8 Dongwei Hui,1
Abdulbaki Agbas,1,2 Xinkun Wang,1,2,3 Mary L. Michaelis,1,2 In-Young Choi,5,6,7 Andrei B. Belousov,5 Greg A. Gerhardt,4
and Elias K. Michaelis1,2,3
1Higuchi Biosciences Center, 2Department of Pharmacology and Toxicology, and 3Life Span Studies Institute, University of Kansas, Lawrence, Kansas
66047, 4Anatomy and Neurobiology, Center for Microelectrode Technology, Morris K. Udall Parkinson’s Disease Research Center of Excellence, University
of Kentucky, College of Medicine, Lexington, Kentucky 40536, 5Department of Molecular and Integrative Physiology, 6Hoglund Brain Imaging Center, and
7Department of Neurology, University of Kansas Medical Center, Kansas City, Kansas 66160, and 8Department of Microbiology, University of Virginia
Health System, Charlottesville, Virginia 22908
The effects of lifelong, moderate excess release of glutamate (Glu) in the CNS have not been previously characterized. We created a
transgenic (Tg) mouse model of lifelong excess synaptic Glu release in the CNS by introducing the gene for glutamate dehydrogenase 1
(Glud1) under the control of the neuron-specific enolase promoter. Glud1 is, potentially, an important enzyme in the pathway of Glu
synthesis in nerve terminals. Increased levels of GLUD protein and activity in CNS neurons of hemizygous Tg mice were associated with
increases in the in vivo release of Glu after neuronal depolarization in striatum and in the frequency and amplitude of miniature EPSCs in
the CA1 region of the hippocampus. Despite overexpression of Glud1 in all neurons of the CNS, the Tg mice suffered neuronal losses in
select brain regions (e.g., the CA1 but not the CA3 region). In vulnerable regions, Tg mice had decreases in MAP2A labeling of dendrites
and in synaptophysin labeling of presynaptic terminals; the decreases in neuronal numbers and dendrite and presynaptic terminal
labeling increased with advancing age. In addition, the Tg mice exhibited decreases in long-term potentiation of synaptic activity and in
spine density in dendrites of CA1 neurons. Behaviorally, the Tg mice were significantly more resistant than wild-type mice to induction
and duration of anesthesia produced by anesthetics that suppress Glu neurotransmission. The Glud1 mouse might be a useful model for
the effects of lifelong excess synaptic Glu release on CNS neurons and for age-associated neurodegenerative processes.
Introduction
Glutamate (Glu) is both a rapidly acting transmitter and a signal-
ing molecule with long-lasting effects on neuronal structure and
function (Cotman et al., 1988; Komuro and Rakic, 1993). Exces-
sive excitation of neurons by Glu causes neurotoxicity (Choi,
1992), a process linked to several pathologic states in the CNS
(Schwarcz and Meldrum, 1985). The molecular and cellular
mechanisms of neurodegeneration caused by acute exposure of
neurons to excess Glu have been studied extensively (Aarts et al.,
2003). However, acute treatments with Glu analogs may not fully
replicate the effects of chronic, localized, moderate excess release
of Glu at synapses occurring throughout the life span of an or-
ganism. Such release may be an important parameter in the con-
trol of synapse structure and function, dendrite and nerve
terminal integrity, or neuronal injury. Changes in synaptic func-
tion and loss of select glutamatergic neurons or their synapses
occur during aging or in age-associated neurodegenerative dis-
eases (Masliah et al., 1993; Morrison and Hof, 1997; Francis,
2003), and changes in Glu release or reuptake are considered
important for the observed synaptic and neuronal losses. How-
ever, the effect of chronic, moderate, transient increases in extra-
cellular Glu in brain on synaptic morphology and function or
neuronal loss has been difficult to produce in experimental ani-
mals in vivo.
Two animal models of excess extracellular Glu accumulation
and the resultant effects on neuronal structure and function are
the null mutant mice for the Glu transporter Slc1a2 (Eaat2) and
the tuberous sclerosis complex-1 (Tsc1) genes. These mice suffer
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extensive brain damage and marked reduction in life span as a
result of loss of function of Glu transporters and high levels of
tonic Glu accumulation (1.5- to 32-fold normal levels) in the
extracellular medium (Rothstein et al., 1996; Tanaka et al., 1997;
Zeng et al., 2007). Neither of these two mutant mice would be a
good model for probing the effects on neurons of moderate in-
creases in depolarization-induced Glu release from nerve termi-
nals across the life span of an organism. To achieve moderate
increases in Glu release by CNS neurons and study the effects of
excess synaptic Glu release on neuronal and synaptic structure
and function, we created transgenic (Tg) mice with extra copies
of the gene for Glud1. The protein GLUD1 is a mitochondrial
enzyme that converts Glu to 2-oxoglutarate (2-OG); the 2-OG
generated in mitochondria is carried to the cytosol of nerve ter-
minals, converted back to Glu, and stored in synaptic vesicles
(i.e., feeds into the pool of releasable Glu) (Palaiologos et al.,
1988). Thus, GLUD activity may regulate Glu transmitter forma-
tion at nerve endings and, generally, Glu homeostasis.
We describe below the generation and characterization of Tg
mice that overexpress the Glud1 transgene in CNS neurons.
These mice exhibited increased Glu release after depolarization,
increased frequency and amplitude of miniature EPSCs (mEPSCs)
in hippocampus, relative resistance to anesthetic agents known to
suppress Glu neurotransmission, age-associated neuronal losses
in select brain regions, age-related alterations in dendrite and
synaptic structures, altered dendrite spine density, and dimin-
ished long-term potentiation (LTP) of synaptic activity.
Materials and Methods
Generation of Glud1 and Egfp Tg mice. Experimental procedures related
to animals followed the procedures of the Institutional Animal Care and
Use Committee of the University of Kansas and those of the National
Institutes of Health. Tg mice were generated by microinjecting fertilized
oocytes from super-ovulating C57BL6/SJL hybrid mice with linearized
DNA containing the cDNA of mouse Glud1 (Tzimagiorgis and Moscho-
nas, 1991). The cDNA was placed under the control of the Nse promoter.
This promoter was excised from pNSE-LacZ vector (Forss-Petter et al.,
1990) by digesting the SV40 polyA tail (BamHI and EcoRI), blunting and
cloning it into pGEM-7Z between SmaI and BamHI. Then the Nse pro-
moter was excised from pNSE-LacZ (BamHI and SphI digestion) and
cloned into the modified pGEM-7Z. A linker containing multiple restric-
tion sites (BglII/EcoRV/HindIII/MluI/XbaI/KpnI; sense sequence, 5-
AGATCTGATATCAAGCTTACGCGTCTAGAGGTAC-3) was cloned
between SphI (blunted) and KpnI of pGEM-7Z, which contained the Nse
promoter and SV40 polyA tail (pNSE-GEM-7Z). The open reading
frame (ORF) of Glud1 cDNA was excised from pUC19 [by SacI 5-
untranslated region (UTR)/HpaI 3-UTR] and subcloned into the
Eco72I site of a reconstructed pSindRep5 Sindbis virus vector, into which
a polylinker (BclI/XhoI/SacI/NotI/PvuI) was introduced. The orienta-
tion of the Glud1 ORF insert was confirmed by sequencing; the insert was
digested (XbaI/XhoI) and cloned into pNSE-GEM-7Z to create the
pNSE-GLUD1 vector. This vector was digested with EcoRI, and the DNA
was microinjected into the pronuclei of 215 fertilized mouse oocytes and
transferred to the oviducts of pseudopregnant mice. Very similar pro-
cedures to those for Glud1 vector construction were used to generate
the vector for microinjection of pNSE-EGFP. A total of 80 oocytes
were injected with the linearized NSE-EGFP vector to generate the
Egfp Tg mice.
Forty-eight pups were born after transfer of oocytes microinjected
with the pNSE-GLUD1 construct. Of these pups, four had the transgene
for Glud1. Genotyping was performed on genomic DNA extracted from
tail biopsies obtained from 3- to 4-week-old pups. The DNA was sub-
jected to Southern blot and PCR analysis. For the identification of the
Glud1 transgene by PCR, the primers used were as follows: F1, 5-
GATATCGGGTGCATCTGAG-3; and R1, 5-GGTTTATGAGGACAC-
AGAGG-3 (900 bp product). PCR amplification was performed using
pfu polymerase and either 100 ng of genomic DNA or 1 ng of DNA from
the pNSE-GLUD1 vector (reaction conditions: 32 cycles of 95°C for 30 s,
53°C for 30 s, 72°C for 1 min). Southern blot analyses were used to
confirm the PCR results. pNSE-GLUD1 and genomic DNA from tail
clippings were digested with EcoRV. A 790 bp fragment from the Glud1
ORF was used as a probe for hybridization with genomic DNA.
Estimation of Glud1 gene copy number. Genomic DNA from founder
Tg and wild-type (wt) mice was extracted (DNeasy tissue kit; Qiagen),
and the DNA concentration was determined (A260/A280 nm; Bioana-
lyzer). Quantitative PCR (qPCR) was used to measure the amount of
Glud1 and Grin1 DNA. The values for Grin1 in each sample were used to
standardize the DNA measurements for the estimation of Glud1 gene
copy numbers in all samples. For measurements of Grin1 DNA, the
primers used were F1, 5-CCAGGCACTACC-3, and R1, 5-GGCTGCA-
GATGGAATGATTA-3; and the qPCR probe for binding to the ampli-
cons was 5-6-FAM-GTGGTTGGGCTGGGCTTTAGATGT-BHQ-1-3
(Biosearch Technologies). For the Glud1 transgene, primers and probe
were designed according to the sequence of exon 1 of Glud1: F1, 5-
GGTGCGCGGCATCCT-3; R1, 5-AACCATGTGTTGAGCCTCTCCT-
3; and probe 5-6-FAM-AGGATCATCAAGCCCTG-NFQ-MGB-3
(Applied Biosystems). The polymerase was ExTaq (Takara), and gene
copy numbers were calculated based on ratios of Glud1 to wt Ct values.
Immunoblot estimates of GLUD1 and NMDA receptor subunit levels. To
measure the levels of GLUD1 protein in wt and Tg mouse brains, whole
brains from 6- to 8-month-old mice were excised and homogenized, and
35 g of protein from each homogenate was analyzed by SDS-PAGE and
immunoblotting (Pal et al., 2003). Anti-GLUD1 antibodies (polyclonal;
Novus Biologicals) were used at 1:1000 dilution. Relative levels of expres-
sion were estimated by densitometry. Homogenates were obtained from
sex-matched littermate pairs of wt and Tg, and the samples processed at
the same time. To measure the levels of NMDA receptor subunits NR1
and NR2A, the hippocampus, striatum, and fronto-parietal cortex were
dissected from three male 6-month-old wt and Tg mice. The P2 fraction
was isolated from homogenates from these three regions as described
below. Equal amounts of P2 protein (50 g) were analyzed by immuno-
blot assays as described above for GLUD1. Immune labeling with NR1
and NR2A (both polyclonal; Millipore) and actin (monoclonal; Milli-
pore) antibodies (1:1000 dilution for all) was performed. Actin was used
as a loading control, and the levels of each receptor subunit in the samples
were estimated as the ratio of immune reaction over that of the respective
actin control (Pal et al., 2003).
Mitochondria and synaptosome preparation and measurement of GLUD
activity in vitro and in situ. Brain tissue from wt and Tg mice was excised
and placed in sucrose buffer containing (in mM) 320 sucrose, 0.5 MgSO4,
10 KCl, 1 dithiothreitol, 1 4-(2-aminoethyl)benzenesulfonyl fluoride hy-
drochloride, 1 sodium orthovanadate, 10 HEPES, pH 7.4 and a mixture
of protease inhibitors (1:100 dilution; Sigma). Both a crude mitochon-
drial (P2) and a purified synaptosome fraction were isolated (Michaelis
et al., 1983). The pelleted organelles were resuspended in 1–2 ml of buffer
(0.32 M sucrose, 10 mM -aminocaproic acid, 0.1 mM EGTA, 1:100 di-
luted protease inhibitor mixture, pH 7.5), aliquoted in small volumes,
and stored at 70°C.
GLUD activity in P2 fractions (50 –100 l samples) was measured after
thawing the samples in 1 ml (final volume) of 50 mM Na-phosphate
buffer, pH 7.4, containing 1 mM potassium cyanide and 0.4% Triton
X-100. The suspension was incubated for 5 min at 37°C and centrifuged
at 16,000  g for 20 min, and the clear supernatant containing extracted
mitochondrial GLUD was used for measurements of enzyme activity.
Protein content was measured (Michaelis et al., 1983), and GLUD en-
zyme assays were performed in either the direction of Glu deamination
(Plaitakis et al., 2000) or the direction of 2-OG amination (Mazon, 1978).
The deamination of Glu was measured at 37°C as follows: 30 g sample
protein was added to the reaction buffer (in mM: 50 Na-phosphate buffer,
pH 7.4, 1 ADP, and 0.2 NAD ) and preincubated for 2 min at 37°C, and
the reaction was initiated by adding L-Glu. The NADH produced was
monitored at 340 nm from 0 to 10 min, and the initial velocity was
calculated. Enzyme activities were measured by varying the concentra-
tions of either Glu (0.05–20 mM) or NAD (0–200 M), while keeping the
concentration of the allosteric activator ADP constant. The KM and Vmax
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values  SEM were calculated using SigmaPlot (Zaidi et al., 1998). The
measurement of time-dependent kinetics of amination of 2-OG in
freshly prepared synaptosomes was performed using similar methods to
those for the P2 fraction and a reaction mixture containing (in mM) 100
potassium phosphate, pH 7.8, 50 NH4Cl, 0.2 NADH, and 2.5 potassium
2-OG. The NADH conversion to NAD  was determined based on the
decrease in absorbance at 340 nm. The integrated Michaelis equation
Vapp  t  ([S0]  [S])  (KM  ln([S0]/[S])) (Wharton and Szawelski,
1982) was used to estimate Vapp and KM.
GLUD activity in brain cells in situ was measured in tissue sections as
described previously (Kugler and Baier, 1992). In brief, 20-m-thick
cryotome sections from Glud1 and wt brains were rapidly frozen in liquid
N2, mounted on slides, air dried at 23°C, and incubated for 20 min in a
medium containing 50 mM Na-Glu, 5 mM NAD , 10 mM NaN3, 5 mM
ADP, 20 mM NaCl, 0.15 mM phenazine methosulfate, 5 mM nitroblue
tetrazolium chloride, 0.05 mM MgSO4, and 0.1  10
3 zinc acetate, in 50
mM HEPES buffer, pH 7.5, plus 22% polyvinyl alcohol. Background
staining was obtained in parallel sections incubated in the absence of Glu.
After rinsing the sections in ice-cold water, they were air dried, and
microscopic images were obtained within 12 h of the end of the reaction.
Magnetic resonance spetroscopy measurements of brain amino acids. 1H
magnetic resonance spetroscopy (MRS) data were acquired from the
hippocampus and striatum of 28 Glud1 Tg and 13 wt mice (age, 9
months) using a Varian 9.4 T system. During the experiments, the ani-
mals were anesthetized (1:1 air:oxygen plus 1–2% isoflurane), and their
core temperature maintained at 37°C. Magnetic field homogeneity was
adjusted using a fast, automatic shimming technique by mapping along
projections (Gruetter, 1993). Spin echo, full-intensity acquired localized
spectroscopy (echo time, 3 ms; repetition time, 4 s) (Mlynarik et al.,
2006) was used to acquire 1H MRS data from voxels (5 l) in hip-
pocampus and striatum. The number of transients for MR spectra was
320 – 480 for the hippocampus and 480 – 640 for the striatum. The con-
centrations of the neurochemicals alanine, GABA, glutamine, and Glu
were quantified using the LCModel (Linear Combination of Model spec-
tra) analysis (Provencher, 1993).
Histology, immunohistochemistry, and labeling with 1,1-dioctadecyl-
3,3,3,3-tetramethylindocarbocyanine. Mouse brains were immersion
fixed in 4% paraformaldehyde in PBS for 72 h at 4°C, cryoprotected
(incubation in 30% sucrose–PBS), and frozen by exposure for 30 s to
2-methyl-butane at liquid N2 temperatures. Coronal sections (24 m
thickness) were cut in a cryotome and transferred to gelatin-coated glass
slides. For staining with methylene blue, the sections were air dried,
stained with 0.5% (w/v) dye solution (5 min at 23°C), rinsed in distilled
H2O, dehydrated through graded ethanol, cleared with xylene, and
mounted with permount. For immunofluorescence staining, sections
were blocked with 3% (w/v) gelatin in PBS (1 h at 37°C), treated with
0.1% Triton X-100 in PBS (15 min at 23°C), and reacted (overnight at
4°C, then for 1 h at 23°C) with the following primary antibodies: anti-
GLUD1 (1:2000), anti-microtubule-associated protein 2A (MAP2A;
monoclonal; 1:500 or 1:1000; Millipore), anti-synaptophysin (poly-
clonal; 1:1000; Millipore), anti-neuron-specific enolase (NSE; monoclo-
nal; 1:250; Millipore), anti-ubiquitin (monoclonal; 1:500; Millipore),
and anti-vimentin (polyclonal; 1:400; Millipore). After rinsing in PBS,
the sections were incubated (2 h at 37°C) with fluorescent dye-labeled
secondary antibodies (Alexa 568 goat anti-rabbit or Alexa 488 goat anti-
mouse; 1:1000 dilution in PBS; Invitrogen) and processed (Pal et al.,
2003). Some sections were double labeled with SYTOX blue (Invitrogen)
plus one of the antibodies. SYTOX labeling was performed after the
reaction with the secondary antibody. The sections were rinsed first in
PBS (5 min at 23°C) and then with Tris-EDTA (TE) buffer (10 mM Tris
and 1 mM EDTA, pH 7.5; 5 min), incubated with dye (1:1000 dilution in
TE; 30 min at 23°C), mounted, and viewed using either a Zeiss LSM 510
Meta confocal (Pal et al., 2003) or a spinning disc Olympus 1X81 micro-
scope. Images were processed using Slidebook 4.1, Image J, and Photo-
shop for quantification of pixel density, dendrite length determination,
spine characterization and density, and three-dimensional reconstruc-
tion of images.
The methods used to stain neurons with both 1,1-dioctadecyl-
3,3,3,3-tetramethylindocarbocyanine (DiI) dye (Invitrogen) and anti-
MAP2A antibodies were those described previously (Kim et al., 2007;
Matsubayashi et al., 2008), with some modifications. The sections were
obtained from mice perfused with 2% paraformaldehyde–PBS. After ad-
ditional fixation of the brain in the same fixative (4 h at 23°C), vibratome
sections (100 m) were cut, DiI crystals were delivered, and the sections
were incubated in PBS for 14 h at 23°C to allow dye diffusion to occur. DiI
crystals were applied to brain sections using micropipettes (Kim et al.,
2007). To prepare the DiI micropipettes, a droplet of DiI dissolved in
N,N-dimethylformamide (0.5% w/v) was placed on the tip of each glass
pipette and dried (3–12 h, 60°C), and the crystals were delivered by
touching the brain sections. After DiI diffusion, the sections were briefly
incubated in 3% gelatin–PBS, followed by incubation for 30 min with
digitonin (0.5 mg/ml in PBS). Labeling with anti-MAP2A antibodies and
imaging by confocal microscopy followed as described above.
Microelectrode measurements of depolarization-induced Glu release and
reuptake in striatum. Glud1 Tg (10 –12 months; n  4) and wt (7–12
months; n  9) male and female mice were group housed in a 12 h
light/dark cycle with food and water ad libitum. Enzyme-based micro-
electrode arrays (MEAs) with platinum (Pt) recording surfaces were fab-
ricated, assembled, and calibrated for in vivo mouse recordings according
to published literature (Burmeister et al., 2000). The MEA assemblies for
in vivo recordings consisted of an enzyme-based working electrode and a
single-barrel glass micropipette (internal tip diameter, 12–15 m) po-
sitioned at an equal distance from the four recording electrode sites
(Burmeister and Gerhardt, 2001; Burmeister et al., 2002). Either an iso-
tonic solution of 70 mM KCl (70 mM KCl, 79 mM NaCl, and 2.5 mM CaCl2,
pH 7.4) or a 5 mM L-Glu solution (in physiological saline, pH 7.4) was
loaded into the single-barrel glass micropipette. Glud1 and wt mice were
anesthetized (1.25 g/kg urethane, i.p.) and placed in a stereotaxic frame
fitted with a mouse adaptor in a manner similar to that described recently
(Burmeister et al., 2002). A 200-m-diameter Ag/AgCl reference elec-
trode was implanted into the frontal cortex at a site remote from the
recording areas. The MEA assemblies were lowered into the striatum in
steps of 500 m (Friedemann and Gerhardt, 1992) using the coordinates
for mouse brain [from bregma: anteroposterior, 1.3; mediolateral,
1.5; dorsoventral (DV), 2.25 to 3.75] (Franklin and Paxinos, 1997).
Solutions were ejected from the glass micropipette using a Picospritzer II
(Parker Hannifin). The volume ejected was monitored using a stereomi-
croscope fitted with a reticule (Friedemann and Gerhardt, 1992). Con-
stant voltage amperometry was performed using a Fast Analytical
Sensing Technology (FAST)-16 electrochemistry instrument (Quan-
teon, L.L.C.) and FAST software for four-channel simultaneous record-
ings (Burmeister and Gerhardt, 2001). All mice were killed at the end of
a recording session by an overdose of anesthetic.
Dose–response studies were performed in each striatal recording site
to determine the maximum K -evoked responses in wt and Glud1 mice.
Amperometric data, time, and pressure ejection marks for each individ-
ual Pt recording site were saved in the recording system. A modified Excel
spreadsheet, in conjunction with individual electrode calibration con-
stants, was used to analyze the L-Glu curves. The maximum signal am-
plitude (peak Glu concentration in micromolars) was determined for
each signal and averaged across each mouse type. Approximately 10 sig-
nals per recording site were obtained from each DV position of the MEA
in the striatum. These signals were averaged into a single data point, thus
generating one data point for each DV position and a maximum of four data
points per pass in the striatum of either hemisphere. Determination of the
average amplitude of Glu released required that the volume of KCl ejected be
carefully matched across experiments. Signals obtained from 70 mM KCl
(100–200 nl) ejections in wt and Glud1 mice were used for analysis.
For the calculation of uptake rate kinetics (micromolars per second),
only amplitudes of L-Glu released ranging between 3 and 13 M were
used in the analyses, regardless of the amount of stimulus needed to
evoke the release. L-Glu uptake followed first-order-rate kinetics. There-
fore, the uptake rate constant (k1) was the logarithmic slope of L-Glu
concentration versus time (sec 1) estimated by use of regression analy-
ses (R 2  0.9). Multiplication of k1 with the maximum amplitude of
Glu signal yielded the uptake rate (micromolars per second).
Slice preparation and electrophysiological recordings. Acute brain slices
were prepared from 2.5- to 3-month-old wt and Tg mice as described
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previously (Belousov and van den Pol, 1997). Briefly, animals were anes-
thetized with isoflurane and decapitated. The hippocampi from both
hemispheres were removed, and coronal hippocampal slices (400 m
thick) were prepared (at 2– 4°C) and kept (at 20 –22°C) in artificial CSF
(ACSF) that contained (in mM) 124 NaCl, 3.0 KCl, 2.0 CaCl2, 2.0 MgCl2,
1.23 NaH2PO4, 26 NaHCO3, and 10 D-glucose (aerated, pH 7.3). A flow
pipe perfusion system was used for slice perfusion at 4 –5 ml/min
(Belousov and van den Pol, 1997).
Measurements of mEPSCs were performed in CA1 pyramidal neurons
using whole-cell voltage-clamp recording in the presence of 1 M tetro-
dotoxin (a voltage-gated sodium channel blocker) in ACSF. A glass re-
cording electrode was filled with an internal solution that included (in
mM) 145 KMeSO4, 10 HEPES, 2 MgCl2, 0.1 CaCl2, 1.1 EGTA, 2 Na-ATP,
0.3 Na-GTP, and 5 QX 314 bromide (a blocker of voltage-activated so-
dium channels; pH 7.2, 3–7M). mEPSCs were recorded in a gap-free
mode at a holding membrane potential of 65 mV using the Multiclamp
amplifier and Clampex software. The frequency and amplitude of mEP-
SCs were analyzed during 10 min recordings using Mini Analysis 5.0
software (Synaptosoft). An mEPSC event was considered if its amplitude
was 	5 pA.
Evoked field EPSPs (fEPSPs) were measured using extracellular re-
cordings. A glass recording electrode filled with 3 M NaCl (2–3 M) was
placed in the stratum radiatum (SR) of the CA1 hippocampal region. A
stimulating electrode made from a pair of Teflon-coated, 90% platinum/
10% iridium wires (50 m inner diameter) was used to evoke fEPSPs by
stimulating the Schaffer collaterals (S48 stimulator; Grass Technologies).
Evoked fEPSPs were recorded as described above for mEPSCs. For the
analysis of fEPSPs, a 30 min baseline recording was established using
low-frequency stimulation (0.033 Hz; 0.05 ms impulse duration) and the
adjusted intensity that induced fEPSPs with 40% of the maximal fEPSP
amplitude. LTP was induced using high-frequency stimulation (HFS)
consisting of 0.05 ms impulse duration, 100 impulses, 100 Hz, with the
same stimulation intensity as that used for baseline recordings. After
HFS, the background electrical stimulation was continued using the
stimulus parameters that were used for the baseline stimulation. The
slope of fEPSPs was determined from the rise time period between
the initial 10% and the final 90% of increase in fEPSP amplitude and was
normalized relative to the average fEPSP slope obtained during baseline
recording. Statistical analysis of fEPSP slopes was done using the data
from a 10 min baseline recording (conducted immediately before HFS)
and a 10 min post-HFS recording (conducted between 50 and 60 min
after HFS). Signals were digitized at 20 kHz, filtered at 5 kHz, and stored
on a personal computer. The tests were conducted blindly to the geno-
type of the experimental animal.
Measurement of loss of righting reflex and recovery from anesthesia. A
group of wt and Tg mice (8 –10 months old) were used to determine
sensitivity to the combination of anesthetics ketamine plus xylazine. The
mice were tested using two different doses of the anesthetics adminis-
tered 7 d apart. In the first study, 200 mg/kg ketamine and 13.3 mg/kg
xylazine were administered intraperitoneally, and in the second study,
132 mg/kg ketamine and 8.8 mg/kg xylazine were injected. Immediately
after the injections, each animal was placed on a heating pad, and the
time to onset of loss of righting reflex (LORR) after the injection and the
duration of LORR were recorded. LORR was defined as the time after
the injection of anesthetics when each mouse lost its ability to right
itself from a supine position to standing on all four paws. Duration of
LORR was defined as the time between loss and recovery of the right-
ing reflex.
Statistical analyses. Student’s t test (two-tailed) statistics were used to
compare protein levels and enzyme activities involving a single measure
of such levels or activities. All comparisons were between littermate male
or female wt and Tg mice. The smallest samples were between groups of
three littermates. Kinetic data points of enzyme activity or Glu release
and reuptake, as well as multiple comparisons across brain regions, strata
of regions, and ages of wt and Tg mice, were analyzed by ANOVA. Post
hoc analyses between groups were performed using either Bonferroni’s or
Tukey’s post hoc test. Statistical significance was defined as p  0.05.
Statistical analysis of the sensitivity to anesthetic agents was by means of
the t test. fEPSP data were performed using ANOVA followed by the post
hoc Tukey’s test and the two-tailed Student’s t test (paired, when possi-
ble) with InStat software (GraphPad Software) and Clampfit 10 software
(Molecular Devices). All data are presented as means  SEM.
Results
Development of Glud1 Tg mice
The Tg mice were generated by pronuclear microinjections of
mouse oocytes (C57BL6/SJL hybrid) with a construct contain-
ing the cDNA for mouse Glud1 under the control of the Nse
promoter. The Nse gene is expressed only in neurons of brain
and spinal cord (Peel et al., 1997). In preliminary studies, pri-
mary neuronal cultures transfected with either pNSE-lacZ or
pNSE-EGFP vector exhibited expression of -galactosidase
(lacZ) or enhanced green fluorescent protein (EGFP) in neuronal
cells but not in glia present in these cultures (data not shown). In
addition, in Tg mice that had the transgene for Egfp under the
control of the Nse promoter, we observed high EGFP fluores-
cence in regions enriched in neuronal cell bodies, not in myelin-
ated axonal tracks (data not shown).
Four founder Tg mice were identified by genotyping as having
the Glud1 transgene. The Glud1 gene-copy number in the
founder mice was estimated by qPCR to be either six or eight
copies (8.1  2.1, 8.5  2.2, 5.7  2.3, and 6.4  2.4 in founders
1– 4, respectively). The founder mice were mated with C57BL/6,
and genotyping revealed a normal Mendelian transmission pattern
of the transgene (supplemental Fig. 1, available at www.jneurosci.
org as supplemental material). All mice used in the present stud-
ies were hemizygous for the transgene, were from the third to
10th generation of crossbreeding, and were derived from all four
founders. No consistent differences were seen in physiological
and biochemical measures between mice derived from founders
with eight and those with six extra Glud1 genes; therefore, the
data from the Tg mice were not segregated on the basis of the
founder mice from which the offspring were derived.
Total brain homogenate from mice (6 – 8 months of age) was
subjected to immunoblot studies to determine GLUD1 levels in
brain. GLUD1 levels in three Tg mice were 28.5  2.6% higher
than in three littermate wt mice ( p  0.01; df  4; t test; n  3
pairs). Biochemical measurements of GLUD enzyme activity in
whole-brain homogenates at a single substrate (5 mM Glu) and
cofactor (200 M NAD) concentration paralleled the protein
immune reactivity measures. The enzyme activity was 35– 40%
higher in Tg compared with wt littermates (data not shown). The
increases in GLUD1 levels and GLUD activity in brain homoge-
nates were likely an underestimate of the increases in this enzyme
in neurons because homogenates contain both glial and neuronal
GLUD, whereas the Glud1 transgene under the Nse promoter
would be expressed in neurons. Because of this consideration,
additional analyses of enzyme activity were performed on the P2
fraction isolated from brain homogenates. This fraction con-
tains mitochondria derived from neuronal and glial cell bod-
ies, as well as those from nerve endings (synaptosomes).
Substrate-dependent kinetics of GLUD activity in P2 revealed
that the Vmax for Glu deamination in Tg mouse P2 was signifi-
cantly (65%) higher than in the wt (Tg, 2.25  0.26 mol  mg1
vs. wt, 1.36  0.2 mol  mg1; p  0.04, t test; n  3). In
contrast, the KM values did not differ significantly between Tg
and wt mice for either the substrate Glu (Tg, 6.0  0.9 mM vs. wt,
4.0  1.1 mM; n  3 pairs; p  0.1) or the cofactor NAD (wt,
124.4  11.1 M vs. Tg, 86.5  3.5 M; p  0.06, t test; n  4). The
observed KM values were in the range of those reported previ-
ously (Shashidharan et al., 1994; Plaitakis et al., 2000; Zhang et al.,
2004). The greater difference between wt and Tg in the Vmax for
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GLUD in the P2 fraction vs. that in whole-brain homogenate was
most likely attributable to the relative enrichment of P2 with
synaptosomes and associated intraneuronal mitochondria.
This assumption was confirmed by estimates of the Vmax for
2-OG amination to Glu in isolated synaptosome preparations.
Based on kinetic analyses of enzyme activity using the inte-
grated Michaelis equation (Wharton and Szawelski, 1982), the
Vmax was 153% higher in Tg than wt brain synaptosomes (Tg,
21.7 M  min 1vs. wt, 8.58 M  min 1). Thus, intraneuronal
mitochondria of Tg mice appeared to be substantially en-
riched in GLUD activity.
The results of in vitro biochemical assays were confirmed by in
situ histochemical detection of GLUD activity in brain (Kugler
and Baier, 1992). The deposition of tetrazolium dye in the pyra-
midal cell layer and dendritic fields of the stratum oriens (SO)
and SR of the hippocampus CA1 and CA3 (supplemental Fig. 2,
available at www.jneurosci.org as supplemental material) re-
gions, and in the molecular layer of the dentate gyrus, was greater
in Tg than wt mouse. Under high magnification, the increased
GLUD activity in SO and SR appeared as labeling within nerve
terminal fields. Marked differences between Tg and wt mice in
the in situ GLUD activity were also detected in the striatum and
cortex (data not shown).
Immunohistochemical studies also showed higher labeling by
anti-GLUD1 antibodies in neurons of all brain regions of Tg
compared with wt mice (e.g., in hippocampal pyramidal neurons
of both CA1 and CA3) (Fig. 1). Densitometric measurements of
GLUD1 immunoreactivity over equal-sized areas (3128 m 2) of
each hippocampal region and each stratum of CA1 and CA3 from
five to seven pairs of 6-month-old wt and Tg mice were used to
quantify the differential levels of GLUD labeling in Tg versus wt
mice. GLUD1 immunoreactivity was 53  7.1% higher in Tg
than wt mice across the three strata of CA1
and 52.9  1.6% higher in Tg than wt
across all strata of CA3. Statistical com-
parison of overall Tg versus wt levels of
GLUD1 immunoreactivity in CA1 and
CA3 indicated significant differences be-
tween Tg and wt mice in both regions
(ANOVA; CA1: df  1, 40; F  10.1; p 
0.003; CA3: df  1, 28; F  25.4; p 

0.0005). There was no significant effect of
region (CA1 or CA3) on GLUD1 immu-
noreactivity (ANOVA with Bonferroni
post hoc comparisons; df  1, 60; F  2.3;
p  0.14) nor of the three strata, SO, stra-
tum pyramidale (SP), and SR ( p  0.5–0.9).
In other words, GLUD1 immunoreactiv-
ity was higher in Tg compared with wt
mouse hippocampus in all strata and all
regions of the hippocampus. Significantly
increased levels of GLUD1 immunoreactiv-
ity in Tg versus wt mice (51.8% higher in
Tg) were also detected in neurons of the ce-
rebral cortex, of layers IV and V (ANOVA;
df  1, 10; F  6.0; p  0.034), and of
other brain regions (data not shown). The
biochemical and immunocytochemical
data were indicative of overall increases in
GLUD1 levels and activity in the brains of
Tg mice, and the increases were not local-
ized to select groups of cells.
Amino acid concentrations in Tg and wt hippocampus and
striatum in vivo
Glud1 expression in neurons of the brain may lead to increases in
Glu formation (Yudkoff et al., 1991) and possibly detectable
changes in whole-tissue concentrations of Glu in the CNS. Also,
because Glu in the cytoplasm of neurons may function as the
precursor for the synthesis of GABA, it is possible that some
change in the concentration of GABA might occur in inhibitory
neurons. In addition, the uptake of released Glu into glia could
produce increases in glutamine levels in Tg mouse brain (Yudkoff
et al., 1989), whereas the excess 2-OG formed in neuronal mito-
chondria and transported into the cytoplasm might lead to de-
creases in alanine as a result of transamination reactions in mice
that overexpress Glud1 (Peng et al., 1991; Erecinska et al., 1994).
To obtain simultaneous measurements of the concentration of
several amino acids in the brains of living mice, we used the MRS
approach for neurochemical measurements in 5 l volume
voxels of hippocampus and striatum. As can be seen in Table 1, in
both hippocampus and striatum, the concentration of Glu was
significantly increased, whereas the levels of GABA and glu-
tamine in the same brain regions were not significantly different
between wt and Tg mice. In contrast, the levels of alanine were
significantly decreased in both regions. The concentrations of all
four amino acids measured by MRS in wt mouse hippocampus
and striatum were close to those previously determined in whole
mouse brain using standard biochemical measurements (Levi et
al., 1967; Agrawal et al., 1968). Based on the MRS measurements,
the expression of Glud1 in neurons brought about moderate in-
creases in Glu concentration in brain without increasing GABA
levels in inhibitory neurons. The lack of changes in glutamine
levels might indicate a relatively small contribution to the pool of
mostly glial glutamine by the extra Glu formed, possibly in com-
Figure 1. Immune labeling of GLUD-immunoreactive sites in CA3 (A, B) and CA1 (C, D) of the hippocampus of 12-month-old Tg
and wt mice. Sections were immunolabeled with anti-GLUD polyclonal antibodies.Scale bars, 50 m.
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bination with a greater rate of conversion of neuronal glutamine
to Glu in Tg mice. Finally, the decreased alanine levels might have
been the result of increases in the transamination reaction be-
tween alanine and excess 2-OG in Tg mice, a reaction that leads to
the formation of Glu.
Increases in stimulus-evoked Glu release from striatal
neurons in vivo
To determine whether Glud1 overexpression leads to not only
excess Glu formation but also increased L-Glu release dynamics in
vivo, a self-referencing MEA for the measurement of Glu release
and reuptake in vivo was used (Burmeister and Gerhardt, 2001;
Burmeister et al., 2002; Thomas et al., 2009). Measurements were
obtained from the striatum of anesthetized wt and Tg mice. Glu
release was evoked by an isotonic solution of 70 mM KCl to sim-
ulate burst firing of Glu projections. The recorded signals were
analyzed for maximum L-Glu amplitude and rate of uptake of
released Glu. Local application of 70 mM KCl for 1–2 s in the
striatum of Tg and wt mice produced robust, reproducible
changes in extracellular L-Glu (Fig. 2); Glu release elicited by KCl
applications was consistently higher in Tg mice (Fig. 2). For con-
sistency in data analysis, only Glu signals elicited by ejections of
100 –200 nl of 70 mM KCl were analyzed to obtain the average
maximum amplitudes in wt (n  35 signals) and Tg (n  18
signals) mice. Ejection volumes of KCl eliciting these signals
were, on average, nearly identical in wt and Tg mice (wt, 140  6
nl; Tg, 134  8 nl; p  0.57; df  50), yet the average maximum
amplitude for Glu release was significantly greater in Tg than wt
mice (wt, 6.3  0.7 M; Tg, 9.9  1.4 M; p  0.016; df  50).
The kinetics of Glu reuptake were determined on the basis of
the temporal dynamics of changes in KCl-evoked Glu release.
Since neurotransmitter uptake follows Michaelis–Menten kinet-
ics (Nicholson, 1995) and is affected by the amount of available
substrate, Glu uptake was analyzed by selecting a subset of signals
with maximum release values in the range of 3–13 M. This range
was chosen because peak Glu values in this range were easily
obtained in both wt and Tg mice. Within this subset of signals
(n  35 signals for wt and n  20 signals for Tg), reuptake rates of
stimulus-evoked Glu release were essentially equal for Tg (1.9 
0.3 M/s) and wt (1.8  0.2 M/s) mice (df  53; p  0.66).
Glu transport into neurons or glia in the vicinity of the MEAs
was also estimated by measuring Glu clearance after local appli-
cation of nanoliter volumes of 5 mM L-Glu. Pressure ejections of
5 mM L-Glu into the striatum of Tg and wt mice produced repro-
ducible Glu responses similar to those seen with 70 mM KCl de-
polarization. Maximum amplitudes ranged, once again, between
3 and 13 M for wt (n  29 signals) and Tg (n  13 signals) mice.
Clearance of exogenously applied L-Glu did not differ signifi-
cantly between Tg (2.5  0.5 M/s) and wt (2.9  0.2 M/s) mice
(df  40; p  0.40). The estimated rates of Glu uptake of endog-
enously released Glu were lower than those for the uptake of
exogenously introduced Glu. The differential rates of Glu uptake
were probably attributable to the electrogenic nature of Glu
transporters as Glu uptake is driven by electrochemical gradients
across the cell membrane (Takahashi et al., 1997; Doble, 1999).
Under the conditions of stimulus-evoked Glu release by the local
application of 70 mM KCl, glial and neuronal membranes would
be depolarized, and thus the rate of Glu uptake decreased com-
pared with the clearance rate of exogenously applied Glu. Never-
theless, the key observation was that both endogenously released
and exogenously introduced Glu had very similar rates of clear-
ance in Tg as they did in wt mice. Therefore, the excess Glu release
after KCl-induced depolarization was not likely the result of di-
minished Glu transport in Tg compared with wt mice.
Anesthetics, such as the urethane that was used in the present
studies, exert their effects by enhancing inhibitory synaptic neu-
rotransmission as well as by inhibiting excitatory neurotransmis-
sion (Hara and Harris, 2002). Resting Glu levels are significantly
attenuated in urethane-anesthetized rats (Rutherford et al., 2007)
and, although both wt and Tg mice received the same dose of
urethane (final dose of 1.25 g/kg), the urethane anesthesia might
have had differential effects on neuronal release of Glu in Tg
compared with wt mice. For this reason, another approach was
pursued to assess possible differential rates of Glu release by CNS
neurons in wt versus Tg mice: recording mEPSCs in vitro from
known excitatory, glutamatergic synapses in the hippocampus.
Increases in synaptic release of Glu at glutamatergic synapses
of the hippocampus
If the enhanced release of Glu after neuronal depolarization de-
scribed above represented synaptic Glu release, then this might be
reflected in increases in the amplitude of mEPSCs or both the
amplitude and frequency of mEPSCs in glutamatergic synapses.
In Drosophila, elevated content of Glu in synaptic vesicles after
overexpression of a vesicular Glu transporter led to increases in
both amplitude and frequency of mEPSCs at glutamatergic syn-
apses (Daniels et al., 2004). Thus, if synaptic vesicle filling is
increased in Glud1 mice as a result of increased cytoplasmic levels
of L-Glu, then both mEPSC frequency and amplitude might be
Table 1. Amino acid levels in adult (9-month-old) mouse hippocampus and
striatum of wt and Tg mice measured by MRS
Brain region/genotype
Amino acid concentration (mol/g)
Alanine GABA Glutamine Glutamate
Hippocampusa
wt 0.79  039 1.85  0.25 3.02  0.46 8.99  1.19
Tg 0.56  0.14 1.85  0.30 3.08  0.42 9.76  0.93
( p  0.02)b ( p  0.99) ( p  0.65) ( p  0.03)
Striatuma
wt 1.40  0.84 2.81  0.54 3.83  0.73 8.01  1.46
Tg 1.01  0.33 2.45  0.61 4.17  0.42 8.87  0.79
( p  0.04) ( p  0.11) ( p  0.08) ( p  0.03)
aA total of 13 wt and 28 Tg mice were used to measure amino acid concentrations in the hippocampus. Amino acid
concentrations in the striatum were measured in 10 of the 13 wt mice and in all 28 of the Tg mice. Data from 20 Tg
mice were included in the calculation of alanine concentration in the hippocampus based on meeting the criteria of
the LCModel for consistency and clarity. The values for the concentration of each amino acid are presented as the
mean  SD.
bStatistical significance of differences between wt and Tg mouse brain measurements is indicated by the p value
(unpaired Student’s t test).
Figure 2. Depolarization-induced Glu release in the striatum of Tg and wt mice. Stimulus-
evoked Glu release in Tg and wt mice was measured using MEAs after pressure ejection of
100 –200 nl of 70 mM KCl at the times shown. Reproducible signals of Glu release were obtained
from both Tg and wt mice. Conc., Concentration.
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increased in glutamatergic synapses of Glud1 mice. Patch-clamp
measurements of mEPSCs in CA1 neurons of the hippocampus
of Glud1 and wt mice indicated highly significant increases in
both frequency and amplitude of mEPSCs in Glud1 versus wt
mice (Fig. 3). A fivefold increase in mEPSC frequency (wt:
0.012  0.004, n  3; Tg: 0.059  0.011, n  4; p  0.017) and a
twofold increase in amplitude of mEPSCs (wt: 6.319  0.19, n 
3; Tg: 11.776  1.51, n  4; p  0.029) were observed, thus
supporting the idea that the increases in Glu release after neu-
ronal depolarization (Fig. 2) occurred at excitatory synapses in
the CNS.
Sensitivity to anesthetic agents and neurological
manifestations in Glud1 mice
Induction of anesthesia by both intravenous and volatile anes-
thetic agents, such as thiopental, propofol, ketamine, ketamine–
xylazine, and enflurane, involves suppression of Glu release and
of postsynaptic Glu receptor activation (Orser et al., 1995; Buggy
et al., 2000; Rozza et al., 2000; Cheng and Kendig, 2003). It was
reasoned that if the Glud1 mice produced and released excess Glu
in glutamatergic synapses, then they might exhibit differential
sensitivity to anesthetic agents such as ketamine or the combina-
tion of ketamine–xylazine. An assessment of anesthetic sensitiv-
ity was undertaken using male and female wt and Tg mice. Two
measures were obtained, time to LORR and duration of LORR.
These measures were obtained using two different doses of the
combination of ketamine and xylazine, 200 and 13.3 mg/kg ket-
amine and xylazine, respectively, and 130 and 8.8 mg/kg. Glud1
mice exhibited significant differences from wt mice in both time
to LORR (longer in Glud1 mice) (Fig. 4A) and total time before
recovery of righting reflex (shorter in Glud1 mice) (Fig. 4B).
These differences between Tg and wt mice were significant under
both dose combinations of ketamine and xylazine. The differen-
tial sensitivity to anesthetic agents could not be ascribed to in-
creased fatty tissue in Tg mice, which might have functioned as a
depot for anesthetic agents thus altering pharmacokinetic prop-
erties in Glud1 mice, because the Tg mice used in these studies
weighed a little less than wt mice (wt, 29.5  0.6 g; Tg, 26.2 
0.6 g; p  0.02; df  11).
Neuronal structure in the brains of Tg mice
Initial examination of neuronal structure in the brains of Tg and
wt mice was performed by staining neurons with methylene blue.
Various regions of the brains from five pairs of Tg and wt mice
(12–20 months of age) were examined. Sections from the hip-
pocampus revealed some thinning of the pyramidal cell layer in
the CA1 field of the hippocampus (Fig. 5A,B) and the ventral
granule cell layer of the dentate gyrus (Fig. 5C,D). Counts of
stained neurons revealed significant decreases in the numbers of
neurons in the CA1 region of the hippocampus of Glud1 mice
compared with wt mice (cells per 1100  2; wt: 194.7  2.3, n  4;
Glud1: 167.3  1.5, n  4; p  0.005) as well as in the granule cell
layer of the dentate gyrus (cells per 6162  2; wt: 406.7  20.3, n 
4; Glud1: 321.3  16.6, n  4; p  0. 05). In addition, neurons in
both the CA1 field and the dentate gyrus appeared shrunken and
darkly stained (pyknotic). The pyknotic appearance of pyramidal
neurons in CA1 and granule neurons in the dentate gyrus of
Glud1 mice was similar to that observed after the injection into
the hippocampus of an inhibitor of brain Glu transporters (Arias
Figure 3. Expression of mEPSCs in CA1 pyramidal neurons. Representative recordings of
mEPSCs in neurons from wt (a) and Tg (b) mice are shown. The bottom trace is an expanded
fragment of the recording that is indicated in the top trace. Calibration: ordinate, 10 pA; ab-
scissa, 1 min (top trace) and 60 ms (bottom trace).
Figure 4. Time to LORR and duration of LORR in wt and Tg mice. The mean (SEM) time
period to LORR after injection with the combination of ketamine plus xylazine (A) and the mean
(SEM) duration of LORR before recovery (B) are shown. Two different dose combinations of
ketamine plus xylazine were used as shown. Statistically significant differences determined by
unpaired Student’s t test are shown (n  5 wt and n  6 Tg; *p  0.05; **p  0.005).
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et al., 1997). The similarities in morpho-
logical changes observed in Glud1 mice
and those produced by the acute injec-
tions of a Glu transporter inhibitor might
be viewed as indirect evidence that en-
hanced expression of Glud1 altered neu-
ronal structure in hippocampus and
dentate gyrus as a result of increases in
extracellular Glu levels.
Besides the neuronal changes in hip-
pocampus, loss of large pyramidal cells
was apparent in layers III–V of the pri-
mary motor/somatosensory cortex of Tg
mice (Fig. 5E,F). The numbers of neu-
rons in layers III–V were indicative of a
significant decrease in the total popula-
tion of stained neurons in somatosensory
cortex layers III–V of Glud1 mice com-
pared with wt mice (Fig. 6). Unlike corti-
cal and hippocampal neurons, other large
neurons, such as the Purkinje neurons of
the cerebellar cortex, did not appear to be
affected by the overexpression of Glud1 in
the Tg mice (data not shown).
Beyond the apparent neuronal losses de-
scribed above, there were marked decreases
in dendrite labeling by anti-MAP2A anti-
bodies in Glud1 mouse neurons; these de-
creases were most apparent in the SR of
the CA1 (Fig. 7). Sections from pairs of
Glud1 and wt mouse brains were pro-
cessed in parallel and fluorescence mi-
croscopy using identical laser intensity
and signal amplification for Tg and wt
mice. The differences in pixel density be-
tween Tg and wt MAP2A labeling in the
SR of CA1 (density per 3128 m 2) were
significant (ANOVA; df 3, 8; F  11.6; p 
0.003). However, unlike the differences in
MAP2A labeling of CA1 neurons, those
for CA3 neurons were not statistically
significant (ANOVA; F  3.4; p  0.24).
Double immune labeling of CA1 neurons
with anti-MAP2A and anti-synaptophysin
antibodies revealed marked decreases in
labeling of nerve terminals in Glud1
mouse hippocampus by the anti-synapto-
physin antibody compared with that in wt
hippocampus (Fig. 7B,D,F,H) (i.e., there
were concurrent decreases in nerve termi-
nal and dendrite labeling in Tg versus wt mouse hippocampus).
The decreases in anti-MAP2A labeling in dendrites of CA1
pyramidal neurons of Glud1 mice were similar to decreases in
MAP2A labeling in hippocampus observed after chemical inhi-
bition of Glu transporters and elevations of extracellular Glu
(Arias et al., 1997). Thus, the decreases in MAP2A labeling in the
Glud1 mouse hippocampus might have been the result of excess
release of Glu into the extracellular space of the brain. Because
increases in Glu concentration and in depolarization-induced
Glu release in Glud1 mice were measured in the striatum (Fig. 2),
that region of the brain was also examined for possible changes in
MAP2A labeling (Fig. 8). The overall labeling of MAP2A in both
dendrites and cell bodies of striatal neurons of Glud1 mice was
decreased, despite the fact that in this brain region the nerve
terminal labeling by anti-synaptophysin antibodies showed little
change from that observed in wt mice (Fig. 8). Because the mi-
croanatomical structure of the striatum is more complex than the
layered structure of the hippocampus, z-plane stacked views of
the striatum were obtained, and three-dimensional reconstruc-
tion was used to allow for a more clear visualization of the anti-
MAP2A and anti-synaptophysin labeling to be studied (Fig. 8).
Also, because of the complex architecture of the striatum, pixel
density measurements over a predominantly dendritic field
could not be obtained. Therefore, measurements of MAP2A pixel
density were based on the overall labeling of neurons and neuro-
nal processes in the striatum. Areas representing large corticospi-
Figure 5. Histological sections through the hippocampus CA1 (A, B), dentate gyrus (C, D), and cerebral cortex (E, F ) of 16-
month-old Tg (A, C, E) and wt (B, D, F ) mice. Sections were stained with methylene blue, and all images were obtained at the same
magnification. Scale bars, 10 m. Gr C D, Granule cell layer, dorsal; Gr C V, granule cell layer, ventral; DG, dentate gyrus. Large
pyramidal (Pyr.) neurons in layers IV–V of cerebral cortex in wt (F, arrow) and the absence of such neurons in Glud1 (E, square) are
pointed out.
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nal tracts through the striatum were avoided in the quantification
of MAP2A pixel density (no immune staining in these tracts).
The measurements obtained revealed significant decreases in
MAP2A labeling in Glud1 mice (pixel density per 9930  2; wt,
37.7  2.1; Glud1, 21.9  1.6; p  0. 005).
Despite the significant loss of immune labeling in dendrites of
pyramidal cells in the hippocampus of Tg mice, it was noted that
the cell bodies of these neurons were generally well labeled by
MAP2A antibodies (Fig. 7) (i.e., there was continued synthesis of
MAP2A in neuronal cells of Glud1 mice). The pattern of MAP2A
labeling observed in Glud1 mice showed some similarities to that
seen after transient, excessive stimulation of NMDA receptors in
brain slices ex vivo (Hoskison et al., 2007), namely decreases in
labeling of dendrites and concurrent increases in labeling of neu-
ronal cell bodies in CA1 pyramidal neurons. However, the ap-
pearance of the dendrites in the CA1 region of Glud1 mice
differed from that of hippocampus slices acutely treated with a
large dose of NMDA, as MAP2A labeling in Glud1 mice was less
suppressed than that in slices treated for a short period of time
with high concentrations of NMDA (Hoskison and Shuttle-
worth, 2006; Hoskison et al., 2007). Furthermore, the dendrites
of CA1 neurons in Glud1 mice did not exhibit the varicosities
observed in neurons treated acutely with NMDA.
To determine the overall structure of dendrites of CA1 and
cortical neurons, brain sections were double labeled by the car-
bocyanine dye DiI and by anti-MAP2A antibodies. Both DiI and
anti-MAP2A labeling in neurons from wt mice was continuous
throughout the length of primary dendrites (Fig. 9). For the
Glud1 mouse CA1 region, labeling by DiI indicated that the pri-
mary dendrite shafts in Tg mice were as intact and continuous in
their structure as those in wt mice (Fig. 9) (i.e., no clear indica-
tions of dendrite varicosities or disruption of structure). How-
ever, MAP2A labeling within the shafts of these dendrites showed
decreased immune reactivity and a pattern of discontinuities
in labeling described above. It was unlikely that the disconti-
nuities in MAP2A labeling resulted from the handling of the
tissue sections, such as differential temperatures during tissue
preparation and fixation (Zhang et al., 2007), because the hip-
pocampi from a wt and a Tg mouse brain were always processed in
parallel and under identical conditions. Nevertheless, the wt hip-
pocampus did not exhibit discontinuities in or “beading” of MAP2A
labeling.
Effects of age on dendrite structure and neuronal numbers in
brains of Tg mice
If synaptic and neuronal losses during the aging process are the
result of abnormal levels or activity of Glu in brain, we wondered
whether the decreases in MAP2A labeling in dendrites of Tg mice
would become more pronounced with advancing age. To address
this question, the loss of MAP2A labeling in dendrites was mon-
itored across age in Tg and wt mice (Fig. 10A). MAP2A immune
labeling in CA1 dendrites of wt and Tg mouse littermates (age,
6 –20 months) indicated a significant decline in labeling in Tg
mice across age (ANOVA; df  1, 25; F  5.3; p  0.03), but not
Figure 6. Neuron cell counts in sensorimotor cortex of wt and Tg mice. Methylene blue-
stained sections similar to those in Figure 5 were analyzed to estimate the total number of
neurons in a set area (7225  2) of layers III–IV of sensorimotor cortex. Neurons were counted as
the total number of neurons and as large pyramidal cells. The counts shown represent the mean
(SEM) for each cell population and were obtained from four wt and four Tg age-matched
mice. Statistically significant differences (paired Student’s t test) are also shown; *p  0.05.
Large Pyr. Neur., Large pyramidal neurons.
Figure 7. Immune labeling of MAP2A (green) and synaptophysin (red) reactive sites in CA1
of hippocampus of 12-month-old wt (A–D) and Tg (E–H ) mice. C, G, Enlarged views of dendrite
labeling by anti-MAP2A antibodies in the SO of CA1 pyramidal neurons. D, H, Superimposed
images of MAP2A- and synaptophysin-immunoreactive sites. Scale bars, 10 m.
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in wt mice (df  1, 25; F  1.63; p  0.21). Although there was a
trend toward decreased MAP2A labeling in the oldest group of wt
mice (20 months), ANOVA did not reveal a significant age effect
nor was the decrease in MAP2A immune labeling at 20 months
significantly different from that at 11 months in wt mice (Bon-
ferroni post hoc analysis). Comparisons between Tg and wt mice
at each age (6, 11, and 20 months) revealed significant differences
for each age group comparison (Bonferroni post hoc analysis, p 
0.0005). Thus, significantly lower levels of MAP2A labeling were
already present in Tg mice at 6 months of age, and MAP2A levels
decreased significantly with advancing age in Tg mice. It should
be noted, though, that from 11 to 20 months, the rates of decrease
in both wt and Tg mouse CA1 were nearly parallel, an indication
that the effect of Glud1 overexpression on dendrite labeling was
superimposed on a trend of an age-dependent decrease in label-
ing in wt mouse CA1.
The preservation of MAP2A labeling in hippocampus neuro-
nal cell bodies of both Tg and wt mice afforded the opportunity to
use images similar to those in Figure 7, to count cell numbers
within equal-sized areas of CA1 and CA3. Some sections were
double stained with SYTOX nuclear stain to confirm the accuracy
of the cell counts. The counts were obtained from the mid-
hippocampus CA1 and CA3 regions (Fig. 10B). There was a
highly significant effect of Glud1 overexpression on cell num-
bers in CA1 (ANOVA; df  3, 8; F  12.1; p  0.002). Post hoc
analyses indicated significant differences between Tg and wt
cell numbers in CA1 at every age tested ( p  0.001– 0.028). A
statistically significant effect of age on CA1 cell numbers was
obtained for Tg (df  2, 23; F  9.1; p  0.001) but not for wt
( p  0.057) mice. However, there was a trend toward decreased
cell numbers with advancing age in wt mice, and these decreases
approximated significant levels for an age effect on neuronal
numbers in wt CA1. Furthermore, the nearly parallel decrease in
neuronal numbers between 11- and 20-month-old wt and Tg
mice might indicate again that the effect of overexpression of
Glud1 in Tg mice was an added effect on a background trend of
age-associated, but not yet significant, neuronal loss in wt mice.
No significant differences between Tg and wt mice were de-
tected for neurons of the CA3 region, nor was there a significant
effect of age on either wt or Tg mouse CA3 neuronal numbers
(Fig. 10B). Since the levels of GLUD immunoreactivity in CA3
Figure 8. Three-dimensional reconstruction of immune labeling of MAP2A (green) and syn-
aptophysin (red) reactive sites in the striatum of 12-month-old Tg (A) and wt (B) mice. z-plane
stacked images (0.1 m thickness) obtained by spinning disc microscopy were used for three-
dimensional reconstruction and quantification of MAP2A- and synaptophysin-immunoreactive
sites. The arrow in B points to green fluorescence (Green Fluoresc.) of MAP2A in dendrites of
striatal neurons. Scale bars, 10 m.
Figure 9. Dual labeling of pyramidal neuron dendrites in the CA1 region of hippocampus by
DiI and MAP2A antibodies. Hippocampus sections from 12-month-old Tg (A–D) and wt (E–H )
mice were fixed and labeled by DiI (red) and anti-MAP2A antibodies (green) as described in
Materials and Methods. A, E, MAP2A-immunoreactive sites. B, F, DiI labeling of neurons. C, G,
Superimposed MAP2A and DiI labeling. D, H, Enlarged images of C and G. Scale bars, 10 m.
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neurons were as high as those in CA1 (see above), these obser-
vations were suggestive of selective vulnerability of CA1 neu-
rons in Glud1 Tg mice. Very similar results in terms of
estimates of cell numbers were obtained when anti-NSE anti-
bodies were used to label neurons in the brains of wt and Tg
mice (data not shown).
Other signs of cell injury in the hippocampi of Glud1 mice
In neurons in culture, Glu-induced cell injury is associated with
intracellular accumulations of ubiquitin-immunoreactive pro-
teins (Mattson et al., 1992). Examination of the hippocampi of Tg
and wt mice at 16 –20 months of age revealed intense immune
staining with anti-ubiquitin antibodies in the SP of Glud1 mouse
CA1 but virtually no ubiquitin staining in littermate wt CA1 (Fig.
11A,B). Extensive ubiquitin immunoreactivity (large aggregates)
was seen in both dentate gyrus and CA1 of 16- to 20-month-old
Glud1 mice. The intermediate filament protein vimentin often
encircles ubiquitin aggresomes in the perinuclear area of non-
neuronal cells (Johnston et al., 1998). In 20-month-old Glud1
mice, ubiquitin aggregates in the hippocampus were colocalized
with vimentin, especially in the perinuclear area of CA1 cells (Fig.
11C–E). Twenty-month-old wt mouse brain had few, dispersed,
and barely detectable ubiquitin- and vimentin-immunoreactive
sites in cells (data not shown). The accumulation of ubiquitin-
containing bodies in hippocampal neurons appeared to be an
age-associated process as neurons in the CA1 region of
9-month-old Glud1 mice had only marginally higher levels of
ubiquitin labeling than the corresponding neurons of age-
matched wt mice (data not shown). Also lacking in neurons of
the 9-month-old Tg mice were the large ubiquitin-containing
aggregates observed in CA1 neurons of Glud1 mice at 16 –20
months of age.
Functional changes in neurons of Glud1 mice: LTP in
Glud1 hippocampus
LTP is known to be diminished during aging and in animal mod-
els of neurodegenerative diseases (Barnes and McNaughton,
1985; Rosenzweig et al., 1997; Lynch et al., 2006; Wang et al.,
2006; Dewachter et al., 2008). We tested the possibility that LTP
in the CA1 region of the hippocampus was differentially affected
by overexpression of the Glud1 gene in neurons, and that such
differential activities in LTP between wt and Tg mice might ap-
pear even in young (2–3 months) animals. The slopes of fEPSPs
measured at baseline were not significantly different between wt
Figure 10. Age-associated changes in MAP2A labeling in dendrites and cell bodies of the
CA1 of hippocampus of wt and Tg mice. A, MAP2A labeling in SR dendrites of the CA1 measured
across age for wt and Glud1 mice. The data shown are means (SEM) of pixel density measure-
ments from equal areas (3128 m 2) from 6 –14 pairs of wt and Tg mice of the indicated ages.
Statistically significant differences among the various groups are presented in Results. B, Cell
counts of neurons obtained from a 3128 m 2 area of SP in CA1 and CA3 of wt and Tg hippocam-
pus. Cell bodies labeled with anti-MAP2A antibodies were counted. Statistically significant
differences among the various groups are presented in Results.
Figure 11. Immune labeling of ubiquitin- and vimentin-like reactive sites in cells of the CA1
region of the hippocampus. A, B, Comparative ubiquitin-like immune reactivity in a 16-month-
old wt (A) and a Tg (B) mouse. An anti-ubiquitin antibody revealed large deposits of ubiquiti-
nylated proteins in the Tg mouse hippocampus. C–E, Immune labeling of ubiquitin-like (green)
and vimentin-like (red) reactive sites in CA1 cells of the hippocampus of a 20-month-old Glud1
mouse. E, Superimposed image of C and D. Arrows point to the nuclei of CA1 pyramidal cells.
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and Tg mice (wt: 0.091  0.007 mV/ms, n  7; Tg, 0.098  0.002
mV/ms in Tg mice, n  8; p £ 0.348, two-tailed unpaired Stu-
dent’s t test). Fast increases in the slope of fEPSPs were induced by
HFS in slices from both wt and Tg animals (Fig. 12). Analysis of
the normalized slopes of fEPSPs using ANOVA indicated statis-
tically significant differences between baseline and post-HFS
conditions for the wt slices (Fig. 12B). For the Tg slices, there
were no statistically significant differences between baseline and
post-HFS in terms of the slope of fEPSPs (Fig. 12B). Although
ANOVA did not detect differences in fEPSP slopes between base-
line and post-HFS in slices from Glud1 mice, analysis of the data
using two-tailed paired Student’s t test revealed statistically
significant differences between baseline and post-HFS fEPSPs.
The normalized slope of fEPSPs recorded from Tg mouse hip-
pocampus slices was 99.6  0.9% at baseline and 114.5  3.9%
after HFS (n  8; p  0.006). Overall, though, the slope of
fEPSPs in the post-HFS period was consistently and signifi-
cantly lower in Glud1 mice compared with that measured in wt
mice (Fig. 12 B).
Alterations in spine density and morphology of hippocampal
and cortical neurons
Possible causes for diminished LTP in Tg mice, even at an early
age, might have been the following: (1) a “prepotentiation effect”
caused by increased extracellular Glu (Coan et al., 1989; Rioult-
Pedotti et al., 2000; Zeng et al., 2007); (2) decreased expression of
postsynaptic Glu receptors, such as the NR2 subunits of NMDA
receptors (Yashiro and Philpot, 2008); (3) cell degeneration or
reduced numbers of dendritic spines caused by chronic Glu over-
activity; and (4) enhanced behavioral stress (e.g., social defeat)
(Kole et al., 2004). A prepotentiation effect attributable to excess
extracellular Glu as a cause of diminished LTP formation in Tg
mice would fit with the observation of increased Glu release from
neurons in Tg mice. With regard to NR2 subunit expression, in
separate studies comparing whole genome transcriptome expres-
sion in wt and Tg mice, the mRNA levels for the NR2 subunits of
NMDA receptors in Tg mouse hippocampus were found to be
increased above those in wt (X. Wang, X. Bao, R. Pal, and E. K.
Michaelis, unpublished observations). In addition, immunoblot
analyses of the P2 fractions from hippocampus, striatum, and
cortex were found to have significant elevations of NR1 and
NR2A protein levels in Glud1 compared with wt mice (supple-
mental Fig. 3, available at www.jneurosci.org as supplemental
material). The increased levels of NMDA receptor subunit mR-
NAs and proteins in Tg compared with wt mice might reflect
increases in gene expression and protein synthesis in neurons as
an adaptive response to the loss of synapses brought about by
excess Glu release. Excess Glu release has been shown to in-
duce shortening or disappearance of dendrite spines (Harris,
1999). Thus, despite increased expression of NMDA receptor
proteins in Tg mouse brains, there may be an overall loss of
dendritic spines and synapses and of functional NMDA recep-
tors at synapses. Such losses could have a significant effect on
LTP induction.
To address the possibility of reduced spines in dendrites of Tg
mice, we counted spines on dendrites in the somatosensory cor-
tex and CA1 region of hippocampus after labeling with DiI (sup-
plemental Fig. 4, available at www.jneurosci.org as supplemental
material). Spine density per 5 m length of dendrites was signif-
icantly reduced in both cerebral cortex and hippocampus neu-
rons of Glud1 mice compared with those of wt mouse (Fig. 13A)
(cortex, p 
 0.005; hippocampus, p 
 0.005; t test). The overall
decrease in spine density in either hippocampus or cortex of Tg
versus wt mice was of the order of 30 – 40%. Different morpho-
logical types of spines, such as mushroom-shaped spines, are
known to be preferentially involved in the induction and estab-
lishment of LTP (Matsuzaki et al., 2004). Therefore, spines on
apical and oblique dendrites of cortical (layers III–V) and hip-
pocampal (CA1 SR) neurons were classified into five morpholog-
ical categories (Tarelo-Acuna et al., 2000), and the numbers of
spines under each category were determined. Because the density
of the wide and ramified spines was very low in both wt and Tg
mice, measurements of those spine forms were not included in
the data shown (Fig. 13B,C). There was a significantly lower
density of both the stubby and mushroom spines in both hip-
pocampus and cortex of Tg compared with wt mice (stubby:
hippocampus, p 
 0.001; cortex, p 
 0.001; mushroom: hip-
pocampus, p  0.009; cortex: p 
 0.001; paired t test). The lower
density of these two types of spines in Glud1 neurons ranged
between 52 and 59% of that in wt mouse neurons (Fig. 13B,C).
The density of thin spines in dendrites of hippocampus and ce-
rebral cortex neurons from Glud1 mice was slightly lower than in
Figure 12. LTP in hippocampal CA1 region of wt and Tg mice. Averaged traces of normalized
(relative to baseline) fEPSP slopes (A) and statistical analyses of data (B) are shown. A, HFS (0.05
ms impulse duration; 100 impulses; 100 Hz) is indicated by a vertical arrow. B, Baseline data are
from 10-min-long background recordings obtained immediately before HFS, and the post-HFS
data are from recordings obtained between 50 and 60 min after HFS. In both panels, data are
shown as means  SEM. The number of recordings from three pairs of mice is shown in Results.
Statistical analysis in B was conducted using ANOVA with post hoc Tukey.
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dendrites from wt mice, but the differences were significant only
for cortical neurons ( p  0.02, paired t test).
Discussion
The overexpression of Glud1 in neurons led to enhanced protein
levels and enzyme activity of neuronal GLUD throughout the
brain, to increases in the levels of Glu in hippocampus and stria-
tum, to increased Glu release into the extracellular environment
after depolarization of neurons in striatum, and to increased
spontaneous Glu release (mEPSCs) in synapses of the hippocam-
pus. Fitting with the pattern of enhanced Glu levels and synaptic
Glu release, the Tg mice exhibited relative resistance to anesthetic
agents that suppress glutamatergic synapses. Overexpression of
Glud1 and the resultant moderate excess Glu formation and re-
lease were correlated with neuronal, dendritic spine, and nerve
ending losses in select regions of the brains of Tg mice, particu-
larly the CA1 region of the hippocampus. And both the excess
Glu release and the loss of dendritic spines may have contributed
to the marked suppression of LTP formation in Tg mice. The
selective nature of neuronal damage in Glud1 mice probably con-
tributed to their survival into early aging, and this afforded the
opportunity to examine the effects of GLUD overexpression and
excess Glu formation and release on neuronal structure and neu-
ronal losses with increasing age.
The in vivo effects of lifelong increases in depolarization-
induced release of Glu on neuronal structure and function have
not been characterized previously. Dendrite varicosities and al-
tered structure, spine shrinking, and cell death result from acute
exposure of CNS neurons to excess Glu or NMDA (Buddle et al.,
2003; Hoskison et al., 2007). However, short exposure to either
Glu or NMDA does not allow for full expression of either adap-
tive responses or repair processes within neurons. Rapid (2 h)
recovery of dendrite integrity can occur after acute exposure to
NMDA (Ikegaya et al., 2001), and dissociation of such recovery
from neuronal cell death (24 h after exposure) has been re-
ported (Hasbani et al., 1998). However, the complexity of the
process of injury within subcellular domains after acute exposure
to Glu, and of the recovery or progression toward death, makes it
difficult to predict, a priori, what the effect of exposure to
chronic, moderate increases in synaptic extracellular Glu might
be on the structure and function of neurons.
Excess expression of GLUD was linked in the Tg mice to se-
lective neuronal losses among pyramidal neurons of the CA1
region of the hippocampus, granule cells of the dentate gyrus, and
large pyramidal neurons of the somatosensory cortex. But, de-
spite the increased expression of Glud1 in all neurons of the CNS,
only select populations suffered losses, whereas other neurons,
either glutamatergic or not, such as CA3 region pyramidal cells
and Purkinje cerebellar neurons, did not suffer as a result of
GLUD overexpression. This finding indicates that a process other
than the overexpression of Glud1 in neurons might be the deter-
minant of neuronal injury or survival. Furthermore, selective
neuronal damage in the brain of Glud1 mice and the survival
of these mice to an age 	21 months distinguished these mice
from null mutant mice for the Glu transporter Slc1a2 or for
the Tsc-1 gene.
Suppression of the activity of Glu transporters, especially glial
transporters, leads to chronically elevated levels of extracellular
Glu that are nearly 30-fold higher than those in wt animals (Roth-
stein et al., 1996). These increases represent tonic rather than
transient elevations of extracellular Glu in Slc1a2 and Tsc-1 null
mutant mice, and the sustained increases in extracellular Glu
have been invoked as the cause of seizures, extensive neuronal
degeneration in the CNS, and early demise of these mutant mice
(Rothstein et al., 1996; Tanaka et al., 1997; Zeng et al., 2007).
Differential neuronal vulnerability to Glud1 overexpression
was not only apparent in selective loss of neurons but also in
selective changes in MAP2A labeling in dendrites. Beyond the
differential rates of neuronal losses during aging in CA1 versus
Figure 13. Spine density and spine morphology distribution in primary and oblique den-
drites of Tg and wt mice. A, The number of spines per 5 m length of dendrites was determined
in 45–75 dendrite segments from three Tg and wt mice. The differences in spine density were
statistically significant as indicated in Results. B, C, The number of stubby, mushroom, and thin
spines per 25 m dendrite length was determined from 30 such segments in hippocampal (B)
and cortical (C) neurons of three Tg and wt mice. The results of statistical analyses are presented
in Results.
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CA3, the CA1 neurons exhibited marked suppression of MAP2A
levels and the appearance of discontinuities in MAP2A labeling,
whereas MAP2A levels in dendrites of CA3 neurons in Tg mouse
brains were as high as those of wt mice and without discontinui-
ties. The selective morphological changes and neuronal losses in
only CA1 neurons of Glud1 mouse hippocampus also differed
from the changes in dendrite structure observed after acute ex-
posure of neurons in organotypic cultures to NMDA. In cultures,
structural changes in dendrites occur in both CA1 and CA3 neu-
rons (Ikegaya et al., 2001).
The presence of dendrite varicosities was an important differ-
ence between the effects of acute exposure of neurons to NMDA
and those observed in Glud1 mouse hippocampus. Dendrite var-
icosities are a consistent finding after acute NMDA treatment,
glucose deprivation, or hypoxia (Park et al., 1996; Hasbani et al.,
1998; Ikegaya et al., 2001; Hoskison et al., 2007). However, in the
Tg mouse hippocampus, DiI labeling revealed that primary and
oblique dendrite shafts exhibited a continuous structure that was
similar to the structure of dendrites in neurons from wt hip-
pocampus, and despite the discontinuities in MAP2A labeling in
Tg mice, there was no evidence of varicosities.
What accounted for the suppressed MAP2A labeling in the
hippocampus, striatum, and cerebral cortex of Glud1 mice is not
known. MAP2A is synthesized in dendrites after transport of its
mRNA into dendrites (Rehbein et al., 2000). It is possible that the
changes in MAP2A immunoreactivity in dendrites of Tg mice
were the result of Glu-induced suppression of local protein syn-
thesis (Marin et al., 1997) or alterations in mRNA trafficking.
MAP2A is also distributed within some dendritic spines and
postsynaptic densities (Caceres et al., 1983; Langnaese et al.,
1996). In postsynaptic membranes, MAP2A is associated with
NMDA receptors and undergoes redistribution after excess Glu
release (Buddle et al., 2003).
Significant reductions in synaptophysin labeling of presynap-
tic nerve terminals were also observed in the CA1 of Glud1 mice.
This led us to consider the possibility of changes in synaptic den-
sity (i.e., spine density) in primary and oblique dendrites. Both
hippocampus and cerebral cortex neurons exhibited significant
decreases in spine density in Tg versus wt mice. The greatest
decreases occurred in mushroom and stubby spines, an impor-
tant change as the remodeling of mushroom spines is closely
linked to LTP induction and maintenance (Matsuzaki et al.,
2004).
With respect to LTP, we observed that although LTP could be
induced in CA1 neurons of the hippocampus from both Glud1
and wt mice, the increases in fEPSPs were significantly sup-
pressed in the Tg mice. Reduction of LTP in the Tg mouse hip-
pocampus might not have been solely the result of decreases in
dendrite spine density, since low-level activation of NMDA re-
ceptors by extracellular Glu preceding the induction of LTP
(Coan et al., 1989), or sustained increases in extracellular Glu
(Zeng et al., 2007), can lead to decreases in LTP.
The morphological changes of brain neurons in Glud1 mice
described above, the increases in Glu levels and in spontaneous
and depolarization-induced Glu release, and the decreases in LTP
induction constitute the endophenotype of the Glud1 Tg mice. In
contrast, the differential sensitivity of Glud1 mice to the anes-
thetic combination of ketamine–xylazine constitutes a behavioral
phenotypic characteristic revealed after drug administration. In
terms of other behavioral phenotypic characteristics, studies of
early generations of Glud1 and wt mice revealed no significant
differences between them in either locomotor behavior or in a
discrimination operant training paradigm (T. McKerchar, Bao, J.
Pinkston, S. Fowler, and E. K. Michaelis, unpublished observa-
tions). Behavioral studies of memory formation in Tg versus wt
mice will have to be performed to determine whether the de-
creases in LTP formation would correlate with loss of memory
formation.
The observations made with Glud1 mice lend support to the
idea that not all glutamatergic neurons suffer equally during ag-
ing as shown for the age-associated neuronal losses in the CA1
versus CA3 region. The neuronal populations in human brain
that seem to be most susceptible to injury with aging (Terry et al.,
1987; Masliah et al., 1993; Morrison and Hof, 1997) are some of
the same populations that were most likely to die in increasing
numbers with advancing age in Glud1 mice. The molecular de-
terminants of selective neuronal vulnerability to age-associated
excess Glu are not known. The development of the Glud1 mice
may allow for the exploration of key molecular events produced
by chronic exposure of neurons to moderate, transient increases
in Glu release.
Aging is also associated with substantial loss of synapses on
glutamatergic neurons (Terry et al., 1987; Masliah et al., 1993).
Changes in Glu activity may explain both neuronal and synaptic
atrophy associated with aging and neurodegeneration (Rothstein
et al., 1990; Morrison and Hof, 1997; Francis, 2003). In Glud1
mice, aging was associated with the appearance of significant
decreases in MAP2A and synaptophysin levels in a vulnerable
region, the CA1 field. MAP2 is important in the maintenance of
the structure of dendrites and the function of signal transduction
complexes in synapses (Harada et al., 2002). Loss of synapses and
altered localization of MAP2A in Glud1 mouse dendrites may be
linked processes that can be studied in greater detail in the future
using this mouse model.
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